Marshall Wace’s EyePoint Inc EYPT Stock Holding History

Marshall Wace’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.09M	Buy	+161,784	New	+$2.42M	﹤0.01%	1757
2024 Q2	–	Sell	-388,955	Closed	-$8.04M	–	2663
2024 Q1	$8.04M	Buy	+388,955	New	+$9.63M	0.01%	823
2023 Q3	–	Sell	-89,115	Closed	-$775K	–	2336
2023 Q2	$775K	Buy	89,115 +41,291	+86%	+$252K	﹤0.01%	1829
2023 Q1	$141K	Buy	47,824 +29,353	+159%	+$105K	﹤0.01%	2454
2022 Q4	$64.6K	Buy	+18,471	New	+$81.5K	﹤0.01%	2828
2022 Q1	–	Sell	-11,608	Closed	-$142K	–	3530
2021 Q4	$142K	Buy	+11,608	New	+$156K	﹤0.01%	3279
2021 Q3	–	Sell	-37,746	Closed	-$340K	–	3136
2021 Q2	$340K	Sell	37,746 -69,201	-65%	-$664K	﹤0.01%	2281
2021 Q1	$1.09M	Buy	+106,947	New	+$1.2M	0.01%	1617

Other funds holding EYPT

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Marshall Wace's EYPT Position: Q1 2026 in Review

Marshall Wace opened a new position in EyePoint Inc (EYPT) in Q1 2026: 161,784 shares worth $2.09M. The stake represents ﹤0.01% of the portfolio and ranks #1757 among its holdings. This is a return to the name: Marshall Wace previously reported a position in EYPT as recently as Q1 2024.

Marshall Wace first reported a position in EYPT in Q1 2021 and has held it in 8 quarters since. The position peaked at $8.04M in Q1 2024. 188 funds tracked by Wall St. Rank hold EYPT as of Q1 2026.

Marshall Wace held 161,784 shares of EyePoint Inc worth $2.09M as of Q1 2026.
EyePoint Inc was a new Marshall Wace position in Q1 2026.
EyePoint Inc made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #1757 holding.
Marshall Wace first reported a position in EyePoint Inc in Q1 2021 and has held it in 8 quarters since.
Marshall Wace's EyePoint Inc position peaked at $8.04M in Q1 2024.
188 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.